ClinicalTrials.Veeva

Menu

Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients

K

Korea University

Status and phase

Enrolling
Phase 4

Conditions

Lung Neoplasms
Delirium
Thoracic Surgery, Video-Assisted
Robotic Surgical Procedures
Aged

Treatments

Drug: Acetaminophen and Ibuprofen
Drug: Normal saline

Study type

Interventional

Funder types

Other

Identifiers

NCT05834569
2023GR0023

Details and patient eligibility

About

The primary aim of this interventional study is to investigate the impact of perioperative administration of Maxigesic (combination of acetaminophen and ibuprofen) on delirium after minimally invasive lung surgery in elderly patients. The Maxigesic group receives a total of 5 doses of Maxigesic (20mg/kg, maximum dose per serving: 1g) every 6 h from immediately after anesthesia induction. The control group receives the same volume of normal saline. Researchers compare the incidence and severity of postoperative delirium for 5 days after surgery.

Enrollment

176 estimated patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 65 years or older undergoing minimally invasive lung lobectomy or segmentectomy

Exclusion criteria

  • Hypersensitivity to the main ingredients and additives of Maxigesic
  • Hypersensitivity to aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs)
  • Alcoholism / Alcohol intoxication
  • Severe hematological abnormalities
  • Bleeding tendency (e.g., Spontaneous bleeding)
  • Severe hepatic dysfunction (AST, AST ≥2.5 * upper normal limit(UNL) or Total bilirubin ≥3.0 mg/dl)
  • Severe renal dysfunction (eGFR <30 ml/min/1.73m2 or Dialysis)
  • Severe heart failure (Left ventricle ejection fraction <30%)
  • Uncontrolled hypertension(HTN) (Systolic blood pressure >180 mmHg)
  • Symptomatic asthma in need of treatment
  • Anticoagulants or antiplatelet agents are maintained for up to 5 days before surgery
  • Barbiturates or tricyclic antidepressants (TCAs)
  • High-dose methotrexate (MTX) for cancer treatment
  • Preoperative cognitive impairment, dementia, or delirium
  • Inability to understand the research and instructions for this study

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

176 participants in 2 patient groups, including a placebo group

Maxigesic group
Experimental group
Treatment:
Drug: Acetaminophen and Ibuprofen
Control group
Placebo Comparator group
Treatment:
Drug: Normal saline

Trial contacts and locations

1

Loading...

Central trial contact

Hye Bin KIM, MD, PhD; Heezoo KIM, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems